| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |